GO:0003975 UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003975 describes the enzyme activity that transfers N-acetylglucosamine-1-phosphate from UDP-GlcNAc to dolichyl phosphate, forming N-acetylglucosaminyl-diphosphodolichol and releasing UMP.
• This reaction is the committed first step of the dolichol-linked oligosaccharide pathway for protein N-glycosylation and is catalyzed by GlcNAc-1-P transferase, encoded by ALG7 in yeast and DPAGT1 in humans.
• The enzyme is an integral membrane protein of the endoplasmic reticulum and its activity is sensitive to the lipid environment, including dolichyl phosphate availability.
• Loss or inhibition of this activity blocks N-glycosylation and has been linked to developmental defects, oogenesis failure, and larval lethality in model organisms.
• Tunicamycin is a classic inhibitor that binds the enzyme and prevents the first step of N-glycosylation, making it a key tool for studying this activity.
• The activity is conserved from archaea to eukaryotes, with archaeal AglH able to complement eukaryotic Alg7, highlighting its ancient evolutionary origin.
Description
UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity (GO:0003975) is a molecular function that catalyzes the transfer of N-acetylglucosamine-1-phosphate from UDP-N-acetyl-D-glucosamine to dolichyl phosphate, yielding N-acetyl-D-glucosaminyl-diphosphodolichol and UMP. This reaction is the first committed step in the biosynthesis of the dolichol-linked oligosaccharide precursor used for protein N-glycosylation in the endoplasmic reticulum. Because N-glycosylation is essential for protein folding, stability, and cell-cell recognition, the enzyme activity encoded by GO:0003975 is fundamental to eukaryotic cell biology. The enzyme responsible, GlcNAc-1-P transferase, is known as Alg7 in yeast and DPAGT1 in humans, and its activity is highly conserved across species. Researchers study this activity to understand congenital disorders of glycosylation, cancer biology, and host-pathogen interactions, as well as to develop inhibitors such as tunicamycin. The reaction requires a lipid substrate, dolichyl phosphate, and occurs in the endoplasmic reticulum membrane, where the enzyme is embedded. In this article, we summarize the definition, mechanism, key genes, disease links, and research methods for GO:0003975, based on authoritative QuickGO data and published literature.
UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity At A Glance
| GO ID | GO:0003975 |
|---|---|
| GO term | UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity |
| Ontology | molecular_function |
| Synonym | GlcNAc-1-P transferase activity; dolichol phosphate N-acetylglucosamine-1-phosphotransferase activity; UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase activity |
| Major function | Catalyzes the first step of dolichol-linked oligosaccharide biosynthesis for protein N-glycosylation |
| Reaction | UDP-N-acetyl-D-glucosamine + dolichyl phosphate = UMP + N-acetyl-D-glucosaminyl-diphosphodolichol |
| Subcellular location | Endoplasmic reticulum membrane |
| Representative genes | ALG7 (yeast), DPAGT1 (human), AglH (archaea) |
| Inhibitor | Tunicamycin |
What Is GO:0003975?
GO:0003975 is defined by QuickGO as the catalysis of the reaction: UDP-N-acetyl-D-glucosamine + dolichyl phosphate = UMP + N-acetyl-D-glucosaminyl-diphosphodolichol. In other words, it is the enzyme activity that attaches a sugar-phosphate unit to a lipid carrier, forming the first lipid-linked sugar intermediate in the N-glycosylation pathway. This activity is synonymous with GlcNAc-1-P transferase, dolichol phosphate N-acetylglucosamine-1-phosphotransferase, and UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase, among other names. The reaction is essential for the assembly of the dolichol-linked oligosaccharide that is later transferred to asparagine residues of nascent proteins.
Why Is UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity Important in Cell Biology?
GO:0003975 is important because it initiates the entire N-glycosylation pathway, a post-translational modification that affects protein folding, stability, and function in all eukaryotes. Without this activity, cells cannot synthesize the dolichol-linked oligosaccharide precursor, leading to severe defects in glycoprotein biosynthesis and cell viability. In humans, mutations in DPAGT1, the gene encoding this activity, cause congenital disorders of glycosylation with neuromuscular symptoms. The activity is also a target for the antibiotic tunicamycin and for antiparasitic drug development, as shown in Plasmodium falciparum. In model organisms, loss of this activity disrupts oogenesis and larval development in Caenorhabditis elegans. Thus, understanding GO:0003975 provides insights into fundamental cell biology, disease mechanisms, and therapeutic opportunities.
• Initiates N-glycosylation, a modification affecting over half of all eukaryotic proteins.
• Mutations in DPAGT1 cause congenital disorder of glycosylation type Ij, with intellectual disability and muscle weakness.
• Tunicamycin, a natural inhibitor of this activity, is widely used to study ER stress and unfolded protein response.
• The activity is essential for oogenesis and oocyte-to-embryo transition in C. elegans.
• It is a potential drug target in Plasmodium falciparum, the malaria parasite.
• The enzyme is conserved from archaea to humans, making it a model for evolutionary studies.
• Its activity is regulated by retinoic acid in P19 embryonal carcinoma cells, linking it to differentiation.
• Amplification of the enzyme occurs in tunicamycin-resistant soybean cells, showing adaptive responses.
• The lipid environment, especially dolichyl phosphate levels, modulates enzyme activity.
• Defects in this activity lead to developmental lethality in nematodes and likely other organisms.
What Happens During UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity?
Substrate recognition and binding
In simple terms: The enzyme grabs two molecules: a sugar carrier (UDP-GlcNAc) and a lipid anchor (dolichyl phosphate).
The enzyme binds UDP-N-acetyl-D-glucosamine and dolichyl phosphate in the endoplasmic reticulum membrane. The lipid substrate dolichyl phosphate is embedded in the membrane, and its availability influences the reaction rate. The enzyme recognizes the UDP-GlcNAc moiety with high specificity, positioning it for transfer.
Catalytic transfer of GlcNAc-1-phosphate
In simple terms: The enzyme cuts the bond between the sugar and UDP, then attaches the sugar-phosphate to the lipid.
The catalytic mechanism involves cleavage of the pyrophosphate bond in UDP-GlcNAc, releasing UMP and transferring N-acetylglucosamine-1-phosphate to dolichyl phosphate. This forms N-acetyl-D-glucosaminyl-diphosphodolichol, the first lipid-linked intermediate. The reaction is reversible in vitro but proceeds forward in vivo due to subsequent metabolic steps.
Product release and membrane insertion
In simple terms: The new lipid-sugar molecule stays in the membrane, ready for the next enzyme.
After catalysis, the product N-acetyl-D-glucosaminyl-diphosphodolichol remains in the endoplasmic reticulum membrane, where it serves as a substrate for the next glycosyltransferase in the pathway. UMP is released into the cytosol. The enzyme itself is an integral membrane protein with multiple transmembrane domains.
Regulation by retinoic acid and differentiation
In simple terms: The activity can be turned up or down when cells change identity.
In P19 embryonal carcinoma cells, retinoic acid treatment increases the activity of this enzyme, linking N-glycosylation initiation to differentiation programs. This regulation may affect the repertoire of glycoproteins during development.
Inhibition by tunicamycin
In simple terms: A natural antibiotic blocks the enzyme, stopping N-glycosylation.
Tunicamycin is a competitive inhibitor that binds to the enzyme and prevents the transfer reaction. Structural studies of the GlcNAc-1-P-transferase-tunicamycin complex reveal the basis for inhibition. This inhibition leads to ER stress and is used experimentally to study N-glycosylation.
Key Genes Involved in GO:0003975 UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity
The following genes encode proteins with UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity or are directly involved in its regulation and study.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DPAGT1 (human) | Encodes GlcNAc-1-P transferase, the enzyme for GO:0003975 | Mutations cause congenital disorder of glycosylation; target for tunicamycin |
| ALG7 (yeast) | Yeast ortholog of DPAGT1 | Model for N-glycosylation and tunicamycin resistance |
| AglH (archaea) | Archaeal GlcNAc-1-P transferase | Complements eukaryotic Alg7; evolutionary studies |
| GPT (mouse) | Mouse UDP-GlcNAc:dolichyl-phosphate N-acetylglucosaminephosphotransferase | cDNA cloning, antibody generation, chromosomal localization |
| DPAGT1 (C. elegans) | Nematode ortholog | Essential for oogenesis and larval development |
| DPAGT1 (soybean) | Plant ortholog | Amplified in tunicamycin-resistant cells |
| DPAGT1 (P19 cells) | Mouse embryonal carcinoma | Regulated by retinoic acid |
| DPAGT1 (Plasmodium) | Malaria parasite ortholog | Target for antiparasitic compounds |
| DOLPP1 | Dolichyl pyrophosphate phosphatase | Regulates dolichyl phosphate levels, affecting GO:0003975 |
| ALG13 | Subunit of ALG7 complex in some organisms | May modulate activity |
| ALG14 | Subunit of ALG7 complex | May modulate activity |
| RPN1 | Oligosaccharyltransferase subunit | Interacts with N-glycosylation pathway |
| RPN2 | Oligosaccharyltransferase subunit | Interacts with N-glycosylation pathway |
| STT3A | Catalytic subunit of OST | Downstream of GO:0003975 |
| STT3B | Catalytic subunit of OST | Downstream of GO:0003975 |
| DDOST | Oligosaccharyltransferase subunit | Downstream of GO:0003975 |
| MAGT1 | Oligosaccharyltransferase subunit | Downstream of GO:0003975 |
| TUSC3 | Oligosaccharyltransferase subunit | Downstream of GO:0003975 |
How Is UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity Regulated?
The activity of UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase is regulated at multiple levels. In P19 embryonal carcinoma cells, retinoic acid increases the enzyme activity, linking it to differentiation. The lipid environment, particularly the concentration of dolichyl phosphate, modulates the enzyme's catalytic efficiency. In tunicamycin-resistant soybean cells, the enzyme is amplified, suggesting a gene dosage response. Additionally, the enzyme may be subject to feedback regulation by downstream intermediates of the N-glycosylation pathway, although specific mechanisms remain to be fully elucidated.
UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DPAGT1 | Congenital disorder of glycosylation type Ij | Patient-derived fibroblasts, knock-in mouse |
| DPAGT1 | Cancer chemoresistance | Tunicamycin-resistant cancer cell lines |
| DPAGT1 (Plasmodium) | Malaria | Plasmodium falciparum culture, enzyme inhibitors |
| DPAGT1 (C. elegans) | Developmental lethality | C. elegans knockout |
| DPAGT1 (soybean) | Tunicamycin resistance | Soybean cell cultures |
Congenital disorders of glycosylation
Mutations in DPAGT1, the human gene encoding GO:0003975 activity, cause congenital disorder of glycosylation type Ij (CDG-Ij), characterized by developmental delay, seizures, and muscular hypotonia. This highlights the critical role of the enzyme in normal development.
Cancer and chemoresistance
Altered N-glycosylation is a hallmark of cancer, and increased activity of this enzyme may contribute to tumor progression. Tunicamycin resistance in soybean cells due to enzyme amplification suggests that cancer cells might upregulate this activity to survive ER stress.
Infectious diseases
The N-glycosylation pathway is essential for the virulence of Plasmodium falciparum, and compounds targeting this enzyme show antiparasitic activity. Thus, GO:0003975 is a potential drug target for malaria.
Developmental defects
In Caenorhabditis elegans, loss of the enzyme causes defects in oogenesis, oocyte-to-embryo transition, and larval lethality, demonstrating its essential role in development.
From UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of GO:0003975 activity? | CRISPR knockout of DPAGT1 in human cell lines |
| How do point mutations in DPAGT1 affect enzyme function? | CRISPR point mutation knock-in of patient variants |
| Can tagged DPAGT1 be used to study localization? | Knock-in of fluorescent or epitope tags |
| What happens when DPAGT1 is overexpressed? | Overexpression constructs in mammalian cells |
| How does retinoic acid regulate DPAGT1? | P19 cell differentiation model |
| Is DPAGT1 essential for development? | C. elegans knockout and rescue |
How to Study the UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive enzyme assay | Catalytic activity of GO:0003975 | Kinetic studies, inhibitor testing |
| Western blot | Protein expression levels | Validation of knockout or overexpression |
| CRISPR knockout screen | Genes affecting tunicamycin sensitivity | Pathway discovery |
| X-ray crystallography | 3D structure of enzyme-inhibitor complex | Drug design |
| RNA-seq | Transcriptional changes upon inhibition | ER stress response |
| Mass spectrometry | Glycan profiling | N-glycosylation status |
| Fluorescence microscopy | Subcellular localization | ER retention |
| Complementation assay | Functional conservation | Evolutionary studies |
Enzymatic activity assays
The activity of GO:0003975 can be measured using radiolabeled UDP-GlcNAc and dolichyl phosphate, followed by extraction of the lipid-linked product and scintillation counting. This method is direct and quantitative.
Western blotting and immunodetection
Anti-peptide antibodies generated against the mouse enzyme can detect protein levels in cells and tissues. This allows researchers to correlate activity with protein expression.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to tunicamycin, revealing pathways that interact with GO:0003975.
Structural biology
X-ray crystallography of the GlcNAc-1-P-transferase-tunicamycin complex has provided atomic-level insights into the enzyme's catalytic mechanism and inhibitor binding.
How CRISPR Can Be Used to Study GO:0003975 UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity
Knockout
CRISPR knockout of DPAGT1 or its orthologs can completely abolish GO:0003975 activity, leading to N-glycosylation defects and cell death. This is useful for studying essentiality and for generating disease models.
Point Mutation
Introducing patient-specific point mutations into DPAGT1 via CRISPR knock-in allows researchers to study how these mutations affect enzyme activity and glycosylation, providing insights into congenital disorders of glycosylation.
Knock-in
Knock-in of epitope tags or fluorescent proteins into the endogenous DPAGT1 locus enables real-time imaging and proteomic analysis of the enzyme without overexpression artifacts.
Overexpression
CRISPR activation or cDNA overexpression can increase GO:0003975 activity, which is useful for studying tunicamycin resistance and for producing glycoproteins in biotechnological applications.
How EDITGENE Supports UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity Research
Researchers studying UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation, development, or disease. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity research.
Frequently Asked Questions About UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity
What is UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity?
It is the enzyme activity that transfers N-acetylglucosamine-1-phosphate from UDP-GlcNAc to dolichyl phosphate, the first step of N-glycosylation, defined as GO:0003975.
What genes are involved in UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity?
The main genes are DPAGT1 in humans, ALG7 in yeast, and AglH in archaea, all encoding the enzyme [2,8].
What is the function of DPAGT1?
DPAGT1 encodes GlcNAc-1-P transferase, which catalyzes GO:0003975 and initiates the dolichol-linked oligosaccharide pathway for protein N-glycosylation.
How is UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity regulated?
It is regulated by retinoic acid during differentiation, by dolichyl phosphate levels in the membrane, and by gene amplification in tunicamycin-resistant cells [3,4,7].
What diseases are associated with UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity?
Mutations in DPAGT1 cause congenital disorder of glycosylation type Ij; the activity is also linked to cancer chemoresistance and malaria parasite viability [6,8].
What is tunicamycin and how does it relate to GO:0003975?
Tunicamycin is an antibiotic that inhibits GlcNAc-1-P transferase, the enzyme for GO:0003975, blocking N-glycosylation and causing ER stress.
How can I measure UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity?
It can be measured using a radioactive assay with UDP-[3H]GlcNAc and dolichyl phosphate, followed by lipid extraction and scintillation counting.
Is UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity conserved in evolution?
Yes, the activity is conserved from archaea to humans; archaeal AglH can complement yeast Alg7.
What happens if UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity is lost?
Loss of activity blocks N-glycosylation, leading to developmental defects, oogenesis failure, and lethality in model organisms.
Can CRISPR be used to study UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity?
Yes, CRISPR knockout, knock-in, and point mutation models of DPAGT1 are powerful tools to study its function and disease relevance.
Conclusion
GO:0003975, UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity, is a fundamental enzyme activity that initiates protein N-glycosylation. Its central role in glycoprotein biosynthesis makes it essential for development and its dysfunction is linked to congenital disorders, cancer, and infectious diseases. The enzyme is conserved across evolution and is the target of tunicamycin, a widely used research tool. Studying this activity using CRISPR-based models and biochemical assays will continue to reveal new insights into glycosylation biology and therapeutic opportunities.
References
- 1. Kanaki N et al.. 2019. UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase is indispensable for oogenesis, oocyte-to-embryo transition, and larval development of the nematode Caenorhabditis elegans.. Glycobiology 29(2):163-178 PMID: 30445613
- 2. Meyer BH et al.. 2017. AglH, a thermophilic UDP-N-acetylglucosamine-1-phosphate:dolichyl phosphate GlcNAc-1-phosphotransferase initiating protein N-glycosylation pathway in Sulfolobus acidocaldarius, is capable of complementing the eukaryal Alg7.. Extremophiles 21(1):121-134 PMID: 27822701
- 3. Zeng Y et al.. 1995. UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase is amplified in tunicamycin-resistant soybean cells.. Eur J Biochem 233(2):458-66 PMID: 7588788
- 4. Meissner JD et al.. 1999. Regulation of UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase by retinoic acid in P19 cells.. Biochem J 338 ( Pt 2)(Pt 2):561-8 PMID: 10024536
- 5. Rajput B et al.. 1992. Mouse UDP-GlcNAc: dolichyl-phosphate N-acetylglucosaminephosphotransferase. Molecular cloning of the cDNA, generation of anti-peptide antibodies and chromosomal localization.. Biochem J 285 ( Pt 3)(Pt 3):985-92 PMID: 1323278
- 6. Fenollar À et al.. 2022. Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparum.. Comput Struct Biotechnol J 20:850-863 PMID: 35222844
- 7. Schutzbach JS. 1997. The role of the lipid matrix in the biosynthesis of dolichyl-linked oligosaccharides.. Glycoconj J 14(2):175-82 PMID: 9111134
- 8. Yoo J et al.. 2018. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.. Nat Struct Mol Biol 25(3):217-224 PMID: 29459785
